Displaying drugs 6101 - 6125 of 6493 in total
Etoposide toniribate
Investigational
Pemlimogene merolisbac
Pemlimogene merolisbac is under investigation in clinical trial NCT03371381 (An Efficacy and Safety Study of JNJ-64041757, a Live Attenuated Listeria Monocytogenes Immunotherapy, in Combination With Nivolumab Versus Nivolumab Monotherapy in Participants With Advanced Adenocarcinoma of the Lung).
Investigational
Retlirafusp alfa
Investigational
Displaying drugs 6101 - 6125 of 6493 in total